Navigation Links
Experimental Drug Slims Obese Monkeys
Date:11/9/2011

trating no signs of nausea or food avoidance."

Within a month after treatment was stopped the monkeys started to gain weight again, the study authors noted.

The researchers are planning to test the drug on prostate cancer patients. These patients are prone to weight gain during hormone therapy, which can lead to arthritis-causing inactivity and a host of other health problems.

In addition, fat cells produce growth hormones that help cancer cells thrive, the researchers explained.

In this study, patients would receive injections of adipotide for 28 days.

"There is an increasingly clear scientific and medical interplay among obesity, metabolic syndrome and several human cancers, such as prostate, breast, colon, ovarian, among others," Arap said.

"Basically, we are in a cancer center and our group in particular has long been interested in this matter as a potentially new therapeutic in prostate cancer patients," he said.

Obesity expert Dr. David L. Katz, director of the Prevention Research Center at Yale University School of Medicine, said that "for those hopeful that pharmacotherapy might ultimately help us overcome epidemic obesity, this study serves up a preliminary dose of encouraging news."

This good news comes in a precautionary package of prior experience, Katz noted. "A study of nine weeks in a small group of genetically select monkeys is a very far cry from evidence in people, in the real world, over a meaningful span of time," he said.

Even weight-loss drugs that appeared to perform well in people over time like rimonabant and sibutramine have all led to disappointment, either because of waning effectiveness or toxicity, Katz noted.

"Adipotide may prove an exception to this rule, but believing it now would be the triumph of hope over experience," Katz said.

"This should not distract us from how much good we could reliably get done right now if we focused on turning what we already know about th
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Experimental Drug Offers Hope for Cystic Fibrosis Patients
2. Experimental Vaccine Shields Monkeys Against Ebola
3. Experimental targeted therapy shows early promise against medulloblastomas
4. Experimental nonsteroidal treatment of asthma shows promise
5. Experimental obesity drug avoids brain effects that troubled predecessors
6. Experimental treatments for cocaine addiction may prevent relapse
7. Experimental TB Test Called Fast and Accurate
8. Experimental Drug Shows Promise for Bone Marrow Disorder
9. Experimental Leukemia Drug Proves a Slam Dunk
10. Experimental Test May Spot Prostate Cancer Earlier, More Accurately
11. Experimental Drug Aids Kids With Nervous System Tumor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Drug Slims Obese Monkeys
(Date:7/29/2014)... (PRWEB) July 29, 2014 Gummy smile ... and dark gums treatments that can enhance and perfect ... a balanced appearance that displays the teeth to their best ... gum tissue or have gums that are dark or discolored. ... to feel self-conscious about their smiles or experience a high ...
(Date:7/29/2014)... Kathleen Doheny HealthDay ... Healthy women at low risk of cardiovascular disease may be ... a short time without harming their hearts, according to a ... Initiative, found that hormone replacement therapy had harmful effects on ... they began the hormone treatments, and much further past menopause. ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 iFitDress.com, one of ... its new selection of 2014 high low wedding dresses ... new gowns are offered at discounted prices, up to 68% ... the big discounts before August 05. , The ... of high low wedding dresses. In the new collection, there ...
(Date:7/29/2014)... WA (PRWEB) July 29, 2014 “Approximately ... one of the most common chronic illnesses,” Western Washington ... addressing the need for those suffering from allergies ... spent on allergy-related health care each year in the ... as a mere way of life for themselves, rather ...
(Date:7/29/2014)... "Acceptance, Recognition, and Control (A.R.C.) Against ... own demons and wants other men to heed the call ... A month later, he had no job, leaving Raymond with ... approached the government for assistance, the emotional disturbance was so ... But this approach didn’t get to the root of his ...
Breaking Medicine News(10 mins):Health News:Gummy Smile Surgeon, Dr. Alex Farnoosh, Now Offers Procedures to Improve Gummy Smiles and Dark Gums 2Health News:Early Hormone Therapy May Be Safe for Women's Hearts 2Health News:Early Hormone Therapy May Be Safe for Women's Hearts 3Health News:2014 High Low Wedding Dresses Provided By iFitDress.com 2Health News:Allergy Sufferers are Urged to Seek Medical Help in Recent Article by Western Washington Medical Group 2Health News:Allergy Sufferers are Urged to Seek Medical Help in Recent Article by Western Washington Medical Group 3Health News:SBPRA Announces the Release of Its Newest Title, "Acceptance, Recognition, and Control (A.R.C.) Against Depression" 2
... from Scripps Research Institute, have identified a sensor that identifies ... of glucose. It acts like a switch that increases or ... other times it helps to convert glucose into fat for ... named Liver X Receptor. Its dual function makes it a ...
... largely to the socializing that takes place there, according to ... keeping fit and losing weight but also for meeting new ... Professor of Social Sciences from the University of Manchester, spent ... motivating them to join health clubs. He wanted to study ...
... promises heavy investment opportunities for Non-Resident Keralites (NRK), making ... long term. ,Kerala Tourism Department has ... 23 – 27 for showcasing the opportunities in the ... a congregation of major hospitals, health insurance companies, policy ...
... malnutrition. In spite of hospitalization the survival rate is less ... a research published concerning certain clinical signs that would indicate ... are at greater risk. ,The international group of researchers ... where 920 children were admitted with severe malnutrition between Septemb ...
... A new study provides the strongest evidence yet that a ... testing and risk assessment// for toxins is wrong when it ... ,Edward J. Calabrese, a scientist at the University of Massachusetts ... 56,000 tests in 13 strains of yeast using 2,200 drugs, ...
... has for the first time identified several genes// whose expression ... cancers – lung, breast, prostate and colon cancer. ,The ... genes, is often lost in tumor cells. This can occur ... deletion of the gene. Loss of tumor suppression function also ...
Cached Medicine News:Health News:Glucose Sensor That Controls Glucose Metabolism Identified 2Health News:New Study Challenges How Regulators Determine Risk 2Health News:Profiling of Cancer Genes May Lead to Earlier Detection Human Cancers 2Health News:Profiling of Cancer Genes May Lead to Earlier Detection Human Cancers 3
(Date:7/29/2014)... July 29, 2014  Cloud Pharmaceuticals, Inc., a ... development, announced today that it has been awarded ... Foundation Small Business Innovation Research (NSF SBIR) program. ... Cloud Pharmaceuticals designs new drugs and drug ... new, innovative cloud computing technology in place of ...
(Date:7/29/2014)... -- Encision Inc. (OTCQB:ECIA), a medical device company owning patented ... minimally invasive surgery, today announced financial results for its ... The Company posted quarterly net revenue of $2.476 ... or $(0.02) per share. These results compare to net ... $311 thousand, or $(0.04) per share, in the year-ago ...
(Date:7/29/2014)... July 29, 2014   ... that it has taken an exclusive worldwide licence to ... a Durham University spin-out company. ... pay an upfront fee, development and commercial milestone payments, ... also taken an option for additional exclusive licences to ...
Breaking Medicine Technology:Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000 2Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 2Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: